There is a rapidly expanding literature on the in vitro antiviral activity of drugs that may be
repurposed for therapy or chemoprophylaxis against severe acute respiratory syndrome‐…

Background. Tenofovir (TFV) causes kidney tubular dysfunction (KTD) in some patients, but
the mechanism is poorly understood. Genetic variants in TFV transporters are implicated; we …

Background Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has been
declared a global pandemic and urgent treatment and prevention strategies are needed. …

Nanomedicine strategies have produced many commercial products. However, no orally
dosed HIV nanomedicines are available clinically to patients. Although nanosuspensions of …

Although interest and funding in nanotechnology for oncological applications is thriving,
translating these novel therapeutics through the earliest stages of preclinical assessment …

Considerable scope exists to vary the physical and chemical properties of nanoparticles, with
subsequent impact on biological interactions; however, no accelerated process to access …

Recent insights into the immunostimulatory properties of nucleic acid nanoparticles (NANPs)
have demonstrated that variations in the shape, size, and composition lead to distinct …

The identification of transporters of the HIV integrase inhibitor raltegravir could be a factor in
an understanding of the pharmacokinetic-pharmacodynamic relationship and reported drug …

Mesenchymal stromal cells (MSCs) have been reported to display efficacy in a variety of
preclinical models, but without long-term engraftment, suggesting a role for secreted factors, …

As nanomedicines have the potential to address many currently unmet medical needs, the
early identification of regulatory requirements that could hamper a smooth translation of …